Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
| Revenue (TTM) | $2.09M |
| Gross Profit (TTM) | 979,290 |
| EBITDA | $-32.13M |
| Operating Margin | -636.00% |
| Return on Equity | -306.80% |
| Return on Assets | -152.10% |
| Revenue/Share (TTM) | $0.73 |
| Book Value | $1.39 |
| Price-to-Book | 0.27 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 0.442 |
| EV/EBITDA | 3.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 34.30% |
| Shares Outstanding | $7.20M |
| Float | $6.70M |
| % Insiders | 18.04% |
| % Institutions | 7.33% |
Volatility is currently expanding